Bio-Rad Laboratories (NYSE:BIO) Earnings Information
Bio-Rad Laboratories last announced its earnings results on October 29th, 2020. The medical research company reported $3.00 EPS for the quarter, beating the consensus estimate of $1.85 by $1.15. The business had revenue of $647.26 million for the quarter, compared to analyst estimates of $567.35 million. Its revenue for the quarter was up 15.5% on a year-over-year basis. Bio-Rad Laboratories has generated $7.06 earnings per share over the last year and currently has a price-to-earnings ratio of 5.1. Bio-Rad Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 11th, 2021 based off prior year's report dates.
Bio-Rad Laboratories Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Bio-Rad Laboratories (NYSE:BIO) Earnings Estimates
2021 EPS Consensus Estimate: $9.50
Bio-Rad Laboratories (NYSE BIO) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)